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Spatiotemporal Expression of MANF in the Developing
Rat Brain
Haiping Wang1, Zunji Ke2, Alexander Alimov1, Mei Xu1, Jacqueline A. Frank1, Shengyun Fang3, Jia Luo1*
1 Department of Molecular and Biochemical Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America, 2 Institute for
Nutritional Sciences, SIBS, CAS, Shanghai, China, 3 Center for Biomedical Engineering and Technology, Department of Physiology, University of Maryland School of
Medicine, Baltimore, Maryland, United States of America

Abstract
Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an evolutionarily conserved neurotrophic factor which
exhibited neuroprotective properties. Recent studies suggested that MANF may play a role in the neural development of
Drosophila and zebra fishes. In this study, we investigated the spatiotemporal expression of MANF in the brain of postnatal
and adult rats. MANF expression appeared wide spread and mainly localized in neurons. In the cerebral cortex, neurons in
layer IV and VI displayed particularly strong MANF immunoreactivity. In the hippocampus, intensive MANF expression was
observed throughout the subfields of Cornu Amonis (CA1, CA2, and CA3) and the granular layer of the dentate gyrus (DG).
In the substantia nigra, high MANF expression was shown in the substantia nigra pars compacta (SNpc). In the thalamus, the
anterodorsal thalamic nucleus (ADTN) exhibited the highest MANF immunoreactivity. In the hypothalamus, intensive MANF
immunoreactivity was shown in the supraoptic nucleus (SON) and tuberomammillary nucleus (TMN). In the cerebellum,
MANF was localized in the external germinal layer (EGL), Purkinje cell layer (PCL), internal granule layer (IGL) and the deep
cerebellar nuclei (DCN). We examined the developmental expression of MANF on postnatal day (PD) 3, 5, 7, 9, 15, 21, 30 and
adulthood. In general, the levels of MANF were high in the early PDs (PD3 and PD5), and declined gradually as the brain
matured; MANF expression in the adult brain was the lowest among all time points examined. However, in some structures,
such as PCL, IGL, SON, TMN and locus coeruleus (LC), high expression of MANF sustained throughout the postnatal period
and persisted into adulthood. Our results indicated that MANF was developmentally regulated and may play a role in the
maturation of the central nervous system (CNS).
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detected in the cerebral cortex, hippocampus and cerebellum; it is
also detected in the liver, heart, lung, kidney and testis [6].
Recently, MANF has been found to regulate the development of
dopaminergic neurons in Drosophila and zebra fishes [15–17]. The
MANF homologous gene in Drosophila, DmMANF is required at the
end of Drosophila embryogenesis for the maturation of the nervous
system. DmMANF maternal and zygotic null mutants caused a total
loss of dopaminergic neurites and drastic reduction in dopamine
levels followed by degeneration of axonal bundles and subsequent
cell death [15,17]. Similarly, knockdown of MANF expression
decreased the dopamine levels and the expression of tyrosine
hydroxylase gene transcripts in larval zebra fishes [18]. These
findings suggest that MANF may play a role in neural
development. To determine the potential involvement of MANF
in the development of central nervous system (CNS), we
investigated the spatiotemporal expression of MANF in the brain
of postnatal and adult rats. We demonstrated that MANF was
developmentally regulated; high levels of MANF were present in
early postnatal days and its expression declined as the brain
matured.

Introduction
Mesencephalic astroctye-derived neurotrophic factor (MANF) is
a 20 kDa secreted protein and is first identified as arginine-rich,
mutated in early stage of tumor (ARMET). It was recognized as a
protein with a high mutation rate in various tumors [1,2]. It is now
known that MANF together with cerebral dopamine neurotrophic
factor (CDNF) belongs to a novel evolutionary conserved protein
family which show neurotrophic and neuroprotective activities [3].
MANF promotes the survival of rat embryonic nigral dopaminergic neurons, but not serotonergic or GABAergic neurons in vitro
[4]. Intrastriatal injection of recombinant MANF protects
dopaminergic neurons against 6-hydroxydopamine (6-OHDA)induced neurodegeneration [5]. MANF transcripts and protein
levels are up-regulated after ischemic and epileptic insults in the
cerebral cortex, suggesting that it may have neuroprotective effects
against neurotoxins and cerebral ischemia [5–8]. We have recently
showed that MANF was induced in response to ethanol
neurotoxicity in the developing brain [9]. MANF is an endoplasmic reticulum (ER) stress responsive protein and shown to
suppress ER stress-induced cell death [8,10–14].
MANF mRNA was detected in both neural and non-neural
tissues. In mouse brains, relative high manf mRNA levels are
PLOS ONE | www.plosone.org
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Figure 1. Detection of MANF. A: Different amount of human recombinant MANF (1–20 mg) were loaded on a SDS-polyacrylamide gel and
subjected to immunoblotting analysis using a rabbit anti-MANF antibody. B: Rat pups of PD15 were sacrificed and perfused. The brain was dissected,
sectioned and subjected to MANF immunohistochemistry (IHC) using a rabbit anti-MANF antibody (1:6,000) as described in the Material and
Methods. Rabbit serum (1:6,000) was used as a control. Images were taken from the cerebral cortex. Scale bar = 100 mm.
doi:10.1371/journal.pone.0090433.g001

mouse secondary antibodies were purchased from GE Healthcare
Life Sciences (Piscataway, NJ). Ketamine/xylazine was obtained
from Butler Schein Animal Health (Dublin, OH). Other chemicals
and reagents were purchased either from Sigma Chemical or Life
Technologies.

Materials and Methods
Materials
Rabbit anti-MANF antibody was purchased from Abcam
(Cambridge, MA). Recombinant MANF protein was expressed
and purified as previously described [10]. Mouse anti-neuronal
nuclei (NeuN) antibody was obtained from Millipore Corporate
(Billerica, MA). Mouse anti-glial fibrillary acidic protein (GFAP)
and calbindin antibodies were obtained from Sigma Chemical Co.
(St. Louis, MO). Mouse anti-tyrosine hydroxylase antibody was
purchased from BD biotechnology (San Diego, CA). Biotinconjugated anti-mouse and anti-rabbit secondary antibodies and
the ABC kit were obtained from Vector (Burlingame, CA). Alexa488 conjugated anti-rabbit and Alexa-594 conjugated anti-mouse
antibodies were obtained from Life Technologies (Grand Island,
NY). Mouse anti-actin, HRP-conjugated anti-rabbit and anti-

PLOS ONE | www.plosone.org

Animals
Pregnant Sprague-Dawley rats were obtained from Harlan
Laboratories (Indianapolis, IN) and maintained in the Division of
Laboratory Animal Resources of the University of Kentucky
Medical Center. All procedures were performed in accordance
with the guidelines set by the National Institutes of Health (NIH)
Guide for the Care and Use of Laboratory Animals and were approved by
the Institutional Animal Care and Use Committee at the
University of Kentucky.
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Immunohistochemistry
The procedure for immunohistochemistry (IHC) has been
previously described with some modifications [19]. Briefly, animals
were deeply anesthetized with intraperitoneal injection of
ketamine/xylazine and then intracardially perfused with PBS
followed by 4% paraformaldehyde in PBS (pH 7.4). The brains
were removed, post fixed in 4% paraformaldehyde for an
additional 24 hours and then transferred to 30% sucrose in PBS.
They were then frozen in OCT compound and sagittal sections at
40 mm were dissected on a freezing sliding microtome (Leica
Microsystems, Wetzlar, Germany). Floating sections were incubated in 0.3% H2O2/30% methanol in PBS for 10 min. After
washing with PBS, sections were mounted on slides and dried on a
50uC heat blocker. The slides were then blocked with 5% goat
serum and 0.5% TritonX-100 in PBS for 1 hour at room
temperature. After blocking, the slides were treated with a rabbit
anti-MANF antibody (1:6,000) overnight at 4uC. After washing
with PBS, slides were incubated with biotin conjugated goat antirabbit secondary antibody (1:1,000) for 1 hour at room
temperature and followed by washing with PBS. Avidin-biotinperoxidase complex was prepared according to the manufacturer’s
instructions. The slides were incubated in the complex for 1 hour
at room temperature. After rinsing, the slides were developed in
0.05% 3,39-diaminobenzidine (DAB) (Sigma-Aldrich, Inc.) containing 0.003% H2O2 in PBS.

Figure 2. Study of developmental expression of MANF in the
cerebral cortex by immunoblotting analysis. A: Rat pups were
sacrificed at the indicated postnatal days (PD1-30). The cerebral cortex
was dissected and homogenized. Equal amount of sample was pooled
(3–5 pups per group) and subjected to immunoblotting analysis using
an anti-MANF antibody described in Fig. 1. B: The relative expression of
MANF was quantified by densitometric analysis. & p,0.05, && P,0.01
compared with PD1; *p,0.05, **P,0.01, ***P,0.001 compared with
PD3, and ### P,0.001, compared with other groups.
doi:10.1371/journal.pone.0090433.g002

Double-labeling Immunofluorescent Staining
The procedure for double-labeling immunofluorecent staining
has been previously described with some modifications [19].
Briefly, rat pups of PD15 were anesthetized and perfused as
described above. The brain sections were prepared at 15–20 mm
thickness, mounted and dried on a 50uC heat blocker. After
blocking with 5% goat serum and 0.5% TritonX-100 in PBS for 1
hour at room temperature, the slides were incubated with a rabbit
anti-MANF antibody together with one of the antibodies for
neural cell markers (GFAP, NeuN, calbindin or tyrosine hydroxylase) overnight at 4uC. After rinsing in PBS, the sections were
incubated with Alexa Fluor488-conjugated anti-rabbit and Alexa
Fluor 594-conjugated anti-mouse IgG in the dark at room
temperature for 1 hour. The brain sections were examined and
recorded by a fluorescent microscopy (IX81, Olympus).

Preparation of Brain Tissues and Immunoblotting
Rat pups were anesthetized by an intraperitoneal injection of
ketamine/xylazine (100 mg/kg/10 mg/kg) and cerebral cortices
were dissected on postnatal day (PD) 1, PD3, PD5, PD7, PD9,
PD15, PD21 and PD30. The brain tissues were immediately
frozen in liquid nitrogen and then stored at 280uC. The protein
was extracted and subjected to immunoblottting analysis as
previously described [9]. Briefly, brain tissues were homogenized
in an ice cold lysis buffer containing 50 mM Tris-HCl (pH 7.5),
150 mM NaCl, 1 mM EGTA, 1 mM PMSF, 0.5% NP-40, 0.25%
SDS, 5 mg/ml leupeptin, and 5 mg/ml aprotinin. Homogenates
were centrifuged at 20,000 g for 30 min at 4uC and the
supernatant fraction was collected. After determining the protein
concentration, equal amount of protein from each pup at the same
time point was collected and pooled. Aliquots of the protein
samples (30 mg) were separated on a SDS-polyacrylamide gel by
electrophoresis. The separated proteins were transferred to
nitrocellulose membranes. The membranes were blocked with
either 5% BSA or 5% nonfat milk in 0.01 M PBS (pH 7.4) and
0.05% Tween-20 (TPBS) at room temperature for one hour.
Subsequently, the membranes were probed with primary rabbit
anti-MANF antibody overnight at 4uC. After three quick washes
in TPBS, the membranes were incubated with a secondary
antibody conjugated to horseradish peroxidase (GE Healthcare
Life Sciences, Piscataway, NJ). The immune complexes were
detected by the enhanced chemiluminescence substrate (PerkinElmer, Waltham, MA). In some cases, the blots were stripped
and re-probed with either an anti-tubulin or an anti-actin
antibody. The density of immunoblotting was quantified with
the software of Quantity One (Bio-Rad Laboratories, Hercules,
CA).

PLOS ONE | www.plosone.org

Statistical Analysis
Quantitative data were presented as the means 6 SD. Statistical
comparisons were analyzed using ANOVA followed by Dunnett’s
test. The results with p,0.05 were considered statistically
significant.

Results
MANF Expression in the Cerebral Cortex
To determine the specificity of anti-MANF antibody for
immunoblotting and immunohistochemistry (IHC), we first used
this antibody to perform an immunoblotting analysis on the
recombinant MANF at various concentrations. We detected a
single band at around 20 kDa and the intensity of signals increased
as the concentrations of recombinant MANF increased (Fig. 1A).
We further performed IHC on the cerebral cortex of rat pups of
postnatal days (PD) 15 using either this anti-MANF antibody or
normal rabbit serum. Positive signals were only detected for IHC
using MANF antibody but not rabbit serum (Fig. 1B). These
results indicated that this antibody specifically detected MANF.
MANF is expressed in the cerebral cortex of mice [6]. We first
examined the developmental expression of MANF in the cerebral
3
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Figure 3. Study of developmental expression of MANF in the cerebral cortex by immunohistochemistry (IHC). A and B: MANF
expression in the frontal, parietal and occipital cortex. IHC images were taken from indicated cortical areas shown above. A image of higher
magnification showed layers in the cortical cortex (B). C: Double labeling immunofluorescent staining was performed to determine the localization of
MANF (green). Neurons and astrocytes were identified by NeuN and GFAP (red), respectively. Images were generated from layer IV of the cerebral
cortex of PD15 pups. Scale bar = 100 mm.
doi:10.1371/journal.pone.0090433.g003
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Figure 4. MANF expression in the substantial nigra. A: Rat pups were sacrificed at the indicated postnatal days. MANF IHC in substantial nigra
was shown. SNC, Substantia Nigra pars Compacta; SNR, Substantia nigra pars reticulata. B: Double-labeling immunofluorescent staining was
performed to determine the localization of MANF (green) in the SNC of PD15 pups. Dopaminergic neurons were indicated by tyrosine hydroxylase
(TH) (red). The indicated square in the top panel is shown at a higher magnification in the bottom panel. TH- positive and negative cells were
indicated by open arrows and solid arrows respectively. Scale bar = 100 mm.
doi:10.1371/journal.pone.0090433.g004

substantia nigra and striatum. Strong MANF immunoreactivity
was observed in the substantia nigra pars compacta (SNpc), and
relatively weak expression was shown in substantia nigra pars
reticulata (SNpr) (Fig. 4A). Double-labeling immunofluorescent
analysis indicated that MANF was localized in both tyrosine
hydroxylase (TH)-positive and negative cells in the SNpc,
suggesting MANF was not specifically expressed in dopaminergic
neurons (Fig. 4B). MANF expression was also detected in the
caudate nucleus (CPu) of the striatum (data not shown), The
temporal pattern of MANF expression in substantial nigra and
CPu was similar to that of the cerebral cortex, that is, a higher
expression was observed during the early postnatal days (PD3-6)
and its expression decreased as the brain matured.

cortex of rat pups by immunoblotting analysis (Fig. 2). As shown in
Fig. 2, the expression levels of MANF were highest on PD3,
gradually decreased as the brain matured, and were the lowest on
PD30 (Fig. 2). We examined the distribution of MANF in the
cerebral cortex by IHC. Strong MANF signal was detected in the
frontal, parietal and occipital cortex on PD3 (Figs. 3A and B).
Higher levels of MANF were found in layer IV and VI of the
cortex in comparison to other layers (Fig. 3B). Consistent with the
results obtained from immunoblotting analysis, the expression of
MANF in the cortex decreased as the brain developed; among all
time points examined, MANF expression was the lowest in the
adult cerebral cortex (Figs. 3A and B). We used double-labeling
immunofluorecent staining to determine the identity of cells
expressing MANF. Neuronal-specific nuclear protein (NeuN) and
glial fibrillary acidic protein (GFAP) were used as the markers for
neurons and astrocytes, respectively. MANF was dominantly
expressed in NeuN-positive cells (Fig. 3C). There was little MANF
signal in glial GFAP-positive cells. The results indicated that
MANF was mainly expressed in neurons.

MANF Expression in the Hippocampus, Thalamus and
Hypothalamus
High expression levels of MANF were observed in the
hippocampus (Fig. 5). Intensive MANF staining was detected in
CA1, CA2 and CA3 as well as in the granule cell layer (GCL) of
dentate gyrus (DG) during the early postnatal days (PD3-6).
MANF was expressed mainly in NeuN-positive cells (data not
shown). The expression of MANF in the hippocampus decreased
as the brain developed.

MANF Expression in the Substantia Nigra
MANF plays an important role in the maintenance and
protection of mesencephalic dopaminergic neurons [4,5,11,15].
We examined the expression of MANF in the developing
PLOS ONE | www.plosone.org
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Figure 5. MANF expression in the hippocampus. A: Rat pups were sacrificed at the indicated postnatal days. MANF expression in the
hippocampus was determined by IHC. CA1 and CA3, Cornu Ammonis 1 and 3 region of hippocampus; DG, dentate gyrus; SUB, subiculum. B: Image of
higher magnification showed CA1, CA3 and DG of hippocampus. Scale bar = 100 mm.
doi:10.1371/journal.pone.0090433.g005

section of the cerebellum of rat pups of PD6, MANF immunoreactivity was observed in the external germinal layer (EGL),
Purkinje cell layer (PCL), internal granule layer (IGL) and the deep
cerebellar nuclei (DCN) (Figs. 8A and B). In early postnatal days
(PD3 and PD6), strong MANF expression was detected in the
EGL and DCN; its expression in these regions decreased as the
brain developed (Figs. 8A and B; data on DCN were not shown).
However, there was little change of MANF expression in the IGL
during the development. Interestingly, MANF expression in
Purkinje cells significantly increased from PD3 to PD30 (Fig. 8B,
C). MANF was mainly expressed in neurons (NeuN-positive) in the
IGL and calbindin-positive PCs (Fig. 8D). The cerebellar granule
cell precursors (CGCPs) in the EGL also displayed strong MANF
expression. These cells were NeuN-negative (Fig. 8D). Purkinje

MANF expression in the thalamus was wide spread. Interestingly, the anterodorsal thalamic nucleus (ADTN) displayed the
highest MANF immunoreactivity in the thalamus (Fig. 6, indicated
by arrows). Generally, the expression of MANF in the thalamus
decreased during the postnatal neurodevelopment. For hypothalamus, the supraoptic nucleus (SON) and tuberomammillary
nucleus (TMN) exhibited a particularly high level of MANF
expression. Unlike other parts of brain, MANF expression in these
two regions remained stable during the postnatal development and
appeared a little higher in adult rats (Figs. 7A and B).

MANF Expression in the Cerebellum
The cerebellum, a morphologically unique part of the brain,
consists of folia which are separated by fissures. In the sagittal
PLOS ONE | www.plosone.org
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Figure 6. MANF expression in the thalamus. Rat pups were sacrificed at the indicated postnatal days. MANF expression in the hippocampus was
determined by IHC. Arrows indicated the anterodorsal thalamic nucleus (ADTN). AVDM, anteroventral thalamic nucleus, dorsomedial part; LDDM,
laterodorsal thalamic nucleus, dorsomedial part. Scale bar = 100 mm.
doi:10.1371/journal.pone.0090433.g006

Figure 7. MANF expression in the hypothalamus. Rat pups were sacrificed at the indicated postnatal days. MANF expression in the
hypothalamus was determined by IHC. IHC images were taken from the indicated area shown above. A: MANF expression in supraoptic nucleus
(SON). B: MANF expression in tuberomammillary nucleus (TMN). OPT, optic tract. Scale bar = 100 mm.
doi:10.1371/journal.pone.0090433.g007
PLOS ONE | www.plosone.org
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bar = 100 mm. C: Images of higher magnification showing MANF
expression in the external germinal layer (EGL), molecular layer (ML),
Purkinje cells (PCs) and internal granule layer (IGL). Scale bar = 100 mm.
D: Double-labeling immunofluorescent staining was performed to
determine the identity of cells expressing MANF. The images showed
the expression of MANF (green), NeuN (red), GFAP (red), Calbindin (red)
and DAPI (blue) in the cerebellum of PD15 rat pups. Scale bar = 25 mm
E: Co-localization of MANF (green) with tyrosine hydroxylase (TH) (red)
in the LC of PD15 rat pups. Scale bar = 100 mm.
doi:10.1371/journal.pone.0090433.g008

cells are NeuN-negative and calbindin-positive which is consistent
with a previous report [20]. Very high MANF expression was
shown in the locus coeruleus (LC) in the pons (Fig. 8A). The LC is
composed of TH-positive neurons [21,22]. Our results indicated
that MANF was localized in TH-positive cells in the LC (Fig. 8E).

MANF Expression in the Olfactory Bulb
The main olfactory bulb has a multi-layered cellular architecture; they include glomerular layer, external plexiform layer,
mitral cell layer, internal plexiform layer and granule cell layer.
The highest level of MANF expression was detected in the mitral
cell layer. Except for mitral cell layer, MANF expression in the
olfactory bulb gradually decreased during the postnatal development (Fig. 9A). On PD3, mitral cell layer was a multi-layer
structure; it became a mono-layer as the brain matured (Fig. 9B).
Double-labeling immunofluorescent staining (Fig. 9C) indicated
the cells in mitral cell layer were NeuN-negative as previously
reported [20]. The mitral cells maintained a strong MANF
expression during the postnatal development and the high
expression persisted to adulthood (Fig. 9).

Discussion
This study examines the spatiotemporal expression of MANF in
the brain of postnatal and adult rats. High MANF expression is
generally observed during the early PDs (PD3-6), then declines
gradually as the brain matures. Early postnatal days are the period
that critical developmental events such as neuronal migration,
differentiation, synaptogenesis and neurogenesis, occur. High
expression during this period suggests that MANF may be
involved in these processes. Despite its name which is associated
with astrocytes, our study indicates that MANF is predominantly
localized in neurons in the CNS. This result is consistent with our
previous findings in the adult rat brain, which show that MANF is
mainly expressed in neurons but poorly expressed in glial cells
[23]. Under focal cerebral ischemia, however, the expression of
MANF was up-regulated in neurons as well as in astrocytes,
oligodendrocytes and microglia [23]. This suggests that MANF
may play dual roles in the CNS; it functions as a regulator of
neuronal development and a neurotrophic/neuroprotective factor
in response to insults. Under stress or pathological conditions,
MANF may be induced from neurons as well as glia to alleviate
the damages.
In the cerebral cortex, neurons in layer IV and VI display
particularly strong MANF immunoreactivity. These layers consist
of early-born neurons. Layer IV, the internal granular layer,
contains different types of stellate and pyramidal neurons, and is
the main target of thalamocortical afferents from thalamus type C
neurons as well as intra-hemispheric cortico-cortical afferents [24].
Layer VI, the polymorphic or multiform layer, contains few large
pyramidal neurons and many small spindle-like pyramidal and
multiform neurons; layer VI sends efferent fibers to the thalamus,
establishing a precise reciprocal interconnection between the

Figure 8. MANF expression in the cerebellum. A: MANF
expression in the cerebellum of PD6 pups was determined by IHC.
DN, deep cerebellar nuclei; LC, locus coeruleus. Scale bar = 100 mm. B:
Rat pups were sacrificed at the indicated postnatal days. MANF
expression in the cerebellum was determined by IHC. Scale

PLOS ONE | www.plosone.org
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Figure 9. MANF expression in the olfactory bulb. A: Rat pups were sacrificed at the indicated postnatal days. MANF expression in the olfactory
bulb was determined by IHC. 1, Glomerular layer (GLL); 2, External plexiform layer (EPL); 3, Mitral cell layer (MCL); 4, Internal plexiform layer (IPL); 5,
Granule cell layer (GL). Scale bar = 100 mm. B: Images of higher magnification showed the MCL. Scale bar = 25 mm. C: Double-labeling
immunofluorescent staining was performed to determine the identity of cells expressing MANF. The images showed the expression of MANF (green),
NeuN (red), GFAP (red) and DAPI (blue) in the MCL of PD15 rat pups. Scale bar = 25 mm.
doi:10.1371/journal.pone.0090433.g009

Cornu Ammonis (CA) region of hippocampus is characterized
by a thin layer of densely packed pyramidal cells. There are three
main subdivisions: area CA1, CA2, and CA3. The CA field is
bordered on one side by the dentate gyrus (DG); this is generally
referred to as the proximal part (CA3). The opposite distal side is
where CA1 meets the subiculum (SUB). In early postnatal days
(PD3), strong MANF expression is observed in all CA regions
(CA1-3) and subiculum (SUB). The granule cell layer (GCL) in the
DG also expressed strong MANF. This layer contains granule cells
that project to the CA3. In the thalamus, high expression is
observed in the ADTA. The ADTA is part of the limbic system
and plays an important role in the control of neuroendocrine and
sympathetic-adrenal function [26]. In these structures, the
expression of MANF declined as the brain matures.
In some structures, however, the expression of MANF remains
high during the postnatal period and the high levels persist into
adulthood. For example, the supraoptic nucleus (SON) and

cortex and the thalamus [25]. Our data suggest that MANF may
be involved in the maturation of these neurons.
MANF is implicated in the development and survival of
dopaminergic neurons [15–17]. We show here that the SNpc
displays high MANF expression while the SNpr has a weak
expression; this is consistent with the role of MANF in maintaining
dopaminergic neurons. Although MANF is expressed in dopaminergic neurons (TH-positive), it is also expressed in other cells
(TH-negative) in the SNpc, supporting the notion that MANF is
not specific for dopaminergic neurons. The caudate nucleus (Cpu)
of the striatum which is highly innervated by dopamine neurons
from SNpc and the ventral tegmental area (VTA) also expresses
MANF. Previous studies focused on the role of MANF in the
development of dopaminergic neurons [15–17]. Since, MANF
expression is not limited to dopaminergic neurons, the impact of
MANF deletion on other neurons needs to be carefully evaluated.

PLOS ONE | www.plosone.org
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tuberomammillary nucleus (TMN) in the hypothalamus exhibit
particularly high levels of MANF expression. These two nuclei
consist of a cluster of magnocellular cells. The cell bodies in the
SON produce a peptide hormone called anti-diuretic hormone
while the neurons in TMN release histamine and is involved with
the control of arousal, sleep and circadian rhythm. The expression
of MANF in PCs of the cerebellum gradually increases from PD3
to 30 and maintains a high level during adulthood. The expression
of MANF in the IGL of the cerebellum is stable throughout the
postnatal development. The locus coeruleus (LC) in the pons is a
norepinephrine (NE)-containing nucleus that modulates many
physiological and pathological conditions including the sleepwaking cycle, movement disorders, mood alterations, convulsive
seizures, and the effects of drugs such as psychostimulants and
opioids. High expression of MANF is observed in the LC
throughout the postnatal development; this warrants further study

of MANF’s role in this nucleus. Mitral cells in the OB are the
primary output cell from the olfactory bulb conveying olfactory
sensory information to higher cortical areas. Consistent high
expression of MANF is observed in mitral cells during the
postnatal period and in adulthood. MANF is localized in the cell
body of mitral cells. In summary, the expression MANF was
developmentally regulated and mainly localized in neurons.
MANF may play a role in the maturation of the CNS.
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